Utah Administrative Code
Topic - Health
Title R388 - Disease Control and Prevention; HIV/AIDS, Tuberculosis Control/Refugee Health
Rule R388-804 - Special Measures for the Control of Tuberculosis
Section R388-804-2 - Definitions
Universal Citation: UT Admin Code R 388-804-2
Current through Bulletin 2024-06, March 15, 2024
(1) The definitions described in Section 26-6b apply to this rule, and in addition:
(a) Tuberculosis. A disease caused by
Mycobacterium tuberculosis complex, i.e., Mycobacterium tuberculosis,
Mycobacterium bovis, or Mycobacterium africanum.
(b) Acid-fast bacilli (AFB). Denotes bacteria
that are not decolorized by acid-alcohol after having been stained with dyes
such as basic fuschsin; e.g., the mycobacteria and nocardiae.
(c) Case of tuberculosis. An episode of
tuberculosis disease meeting the clinical or laboratory criteria for
tuberculosis as defined in the National Notifiable Diseases Surveillance System
(NNDSS). The Department incorporates by reference the Tuberculosis 2009 Case
Definition, CSTE (Council of State and Territorial Epidemiologists) Position
Statement, 09-ID-65.
(d)
Tuberculosis infection. The presence of M. tuberculosis in the body but the
absence of clinical or radiographic evidence of active disease as documented by
a significant tuberculin skin test, or Interferon Gamma Release Assay (IGRA),
e.g. Quantiferon or T-SPOT, a negative chest radiograph and the absence of
clinical signs and symptoms.
(e)
Tuberculosis disease. A state of active tuberculosis, pulmonary or
extra-pulmonary, as determined by a chest radiograph, the bacteriologic
examination of body tissues or secretions, other diagnostic procedures or
physician diagnosis.
(f) Directly
observed therapy A method of treatment in which health-care providers or other
designated individuals physically observe the individual ingesting
anti-tuberculosis medications.
(g)
Drug resistant tuberculosis. Tuberculosis bacteria which is resistant to one or
more anti-tuberculosis drugs.
(h)
Multi-drug resistant tuberculosis. Tuberculosis bacteria which is resistant to
at least isoniazid and rifampin.
(i) Suspect case. An individual who is
suspected to have tuberculosis disease, e.g., a person with signs and symptoms
consistent with tuberculosis, having AFB recovered from sputum or any other
source with identification pending, or started on a regimen consistent with
treatment for active tuberculosis disease as described in references a & b
in
R388-804-6(1).
(j) Program. Utah Department of Health:
Bureau of Epidemiology; Prevention, Treatment, and Care Program.
(k) Department. Utah Department of
Health.
Disclaimer: These regulations may not be the most recent version. Utah may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.